INTRODUCTION
Cancer is a major cause of morbidity and mortality in developed countries and of increasing concern in developing countries. Its treatment is often costly and associated with high mortality, whereas screening and early diagnosis is life saving.
Epidemiological surveys indicate that patients with certain cancers often have a family history of cancer (1). Familial cancers with clear patterns of mendelian inheritance are very rare. However in the past decade many genes responsible for these rare disorders have been identified (1).
The cancer genes characterised and known inheritance patterns are associated with specific cancer syndromes comprising two or more malignancies in "cancer families". Targeted genetic testing and screening of susceptible individuals is being carried out in developed countries. For example it has been found that screening and genetic testing (for BRCA 1 and 2 genetic markers) reduces breast cancer mortality and has important implications in the natural history of the disease. Evidence suggests that metastases occur very early in breast cancer and it should be considered a systemic disease from the onset due to delay in diagnosis of majority of cases. Studies show that targeted surveillance, therefore earlier screening of women with a family history of breast cancer leads to improved survival (2) . Breast cancer is the most common malignancy in women in Kenya making up 23.3% of women cancers (3). In the Kenyan woman, it occurs more in premenopausal ages, is a more aggressive disease presenting with metastases in 88% of the cases, with higher grades but similar histological types to white women (4). There is lower postitivity both endochrine receptors and Her/neu 2 receptors (5), which correlates with poorer prognosis. African American women have similar poor prognostic indicators and a 37% higher mortality than white women, in whom early referral and treatment is aimed at (6) . In our setup high risk individuals from "cancer families" can undergo targeted screening that can be cost effective and life saving.
MATERIALS AND METHODS
Cases were recruited from KNH medical, surgical and radiotherapy outpatient clinics and Nairobi Hospital's radiotherapy unit. Most cancer patients seen at KNH were outpatients due to the hospital policy of limiting admission of chronic patients. KNH inpatients were not included because of logistics of covering all the wards, difficulty in consecutive sampling of inpatients and potential for selection bias. The KNH radiotherapy clinic operates as outpatient oncology follow-up clinic.
Inclusion and exclusion criteria:
Patients with a documented diagnosis of cancer who consented to participation in the study were recruited. Secondary malignancies, such as HIV and post-transplant associated cancers were excluded.
Two research assistants assisted in screening the daily clinic attendance files for histological report of cancer. These patients were approached using a standardised information sheet. A written informed consent was obtained.
The principal investigator administered a standardised questionnaire to all the index cases and accompanying relatives. If no relative had accompanied the patient, their relatives were contacted and interviewed. A follow-up was made to interview other relatives who corroborated the presence or absence of a family history of cancer. Contact telephone numbers and addresses of relatives to be interviewed were provided by the index cases.
Cancer type and demographic details of the index case were documented. Family history of cancer in patient's first and second degree relative was sought. A detailed family medical history of these relatives was taken. An "important-other" family member, based on educational level, prominence and influence in the family and a willingness to cooperate with the investigator, was identified and interviewed in person, via telephone or mail, seeking to confirm the family history as reported by index case and accompanying relatives. Cancer type, institution where diagnosis was made, attending physician, year of diagnosis, follow-up clinic as well as demographics of the other relative with cancer were noted. This helped in accessing documentary evidence of the same. If alive the relative with cancer was interviewed in person or via telephone contact.
Documentary evidence of the relatives' with cancer was also sought from the existing cancer registries in KNH and KEMRl (Kenya Medical Research Institute), other hospital records, death certificates, pathology reports and verbal corroboration from attending physicians were sought. Consequently the level of evidence, of a family history of cancer was categorised on basis of level of cross validation as follows:
Confirmed: Documentary evidence obtained ,such as hospital discharge summaries, record cards, DXT cards ,histology reports, prescriptions and perusal of attending physicians' notes.
Highly probable: Verbal confirmation of history by relatives who were medical for example doctors, clinical officers or nurses, as well attending physicians.
Probable: Verbal corroboration from patient and two other relatives including the "important-other relative".
Least probable: Verbal confirmation from patient and any other relative.
RESULTS
Five hundred and thirteen cases were screened and 485 were recruited during the period of June to November 2003; 78.8% of sample from KNH, and 21.2% from Nairobi Hospital. Male to female ratio was 1:1.5 and age ranged from 13 to 93 years, with 44% in the 31 to 50 years age group and 16.7% in 60 to 80 years. Sixty eight per cent drawn from rural and 32% from urban areas. They were mainly from Central province, followed by Nyanza, Eastern and Coast provinces. This follows the referral patterns of outpatients attending clinics in KNH. The ethnicity of index cases also follows the catchments area of the two hospitals implying unbiased sampling.
Educational levels of the index cases were: 17.3% no formal education, 37.7% primary, 28.7% secondary and 16.3% tertiary level. The Nairobi Hospital cohort had higher levels of formal education while 64% of KNH cohort had primary level education or had received no formal education at all.
Index cases had 45 different cancer types, with the most frequent being breast (13.8%) and uterine cervix (14%). Post-nasal tumour (11%), skin cancers (6.9%), non PNS head and neck tumours (6%) and laryngeal cancers 5%.
A prevalence of family history of cancer was established in 18.8% (95% C.I 15 22%). Prevalence of positive family history was 12.4% among 1 st degree relatives and 6.4% in 2 nd degree relatives. Some families had a multiple family history of cancer; 25% had more than one relative with cancer, two cases had four relatives each with cancer. A total of 125 relatives had cancer from 91 index cases Family history of cancer was validated as confirmed or highly probably in 59.4% of cases (Table 1) . On stratifying according to hospital and educational level of index cases, a higher prevalence of positive family Approximately 16.8% of relatives were living, half of whom were interviewed, while 83.2% were dead. Relatives with cancer had an age distribution skewed to the right and majority were aged over 60 years ( Figure 1 ) and of male gender (54%). There were 61% first degree relatives and 39% second degree relatives among the relatives with cancer. Of the 66 breast cancer index cases 36% had a family history of cancer; 66% were first degree relatives and 34% were second degree relatives. There were 67 index cases with cancer of cervix, of these 21% had a family history of cancer and 43% were first degree relatives and 58.2% second degree relatives. There were 125 relatives with 24 different cancers, the most common being cancers of uterine cervix and breast; a frequency pattern similar to that of index cases (Figure 2 ). 
Figure 2 The common cancer types among relatives of index cases

DISCUSSION
We found a prevalence of familial clustering of cancer of 18.8% (95% C.I 15 -22%). This is the first such data in this region, as no data is available for sub-Saharan Africa but our data correlated with Western data in several areas. The general population risk for various malignancies ranges from 5 -25% (7, 8) . In Utah and California combined data on 44,788 pairs of twins showed increased familial risk among twins of patients with stomach, colorectal, lung, prostate and breast malignancies (9) . We found a familial clustering of 36% in breast cancer patients, while a Stockholm study showed 35% in breast cancer as well, with a younger age of onset in the familial group (10) . All these studies used cancer registry data in contrast to recall as utilised in our study. Our finding may be an underestimate due to the various biases limiting verification of the family history of cancer. Recall bias was a major shortcoming of this study. Under reporting on account of illiteracy, lack of inter-family communication, geographical constraints, stigma of the disease and confidentiality issues can be expected to have biased our finding to the null. Poor record keeping and lack of updated cancer registries, limited verification of the information obtained. Over estimating on account of misclassification bias was minimised by verification of information at various levels. Limiting the analysis to verified confirmed family history of cancer gave a prevalence's similar to those in studies in which cancer registries were utilised.
Survival bias limited recruitment of cancer types that are rapidly fatal, as depicted by only three cases of hepatocellular cancer yet it is among the top five malignancies in our country.
Our findings are generalisable to the Kenya cancer population; firstly because our sample was unbiased, as is evident from the similar national cancer frequencies (11) and demographics of the index cases to those of other chronic disease patients attending outpatient clinics at the KNH (12) . Secondly, KNH is the only national cancer referral treatment centre and third, the general population lack of awareness about possible familial clustering of cancer is not expected to have contributed significantly to a referral bias. As reported in European studies, we documented a higher prevalence in first degree as apposed to second degree relatives, and we view this as further validation evidence (13) . In some studies monozygotic twins have higher cancer risk than dizygotic twins of cancer patients (14) .
Uterine cervical cancer in our sample did not have a strong familial predilection as has been similarly reported in epidemiological data from the US and Europe with the occurrence being predicted more by environmental factors such as number of sexual partners, age at first intercourse and HPV infection (15) . Investigators reporting clustering of cervical cancer in families have argued that these individuals shared the same environment and have common lifestyle patterns hence tendency to be infected with HPV (16 
